GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma-Reference-Cited by-同舟云学术

GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma

Published:2020-07-14 Issue:1 Volume:56 Page:155-166
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Muranushi Hiroyuki,Shindo Takero^ORCID,Hishizawa Masakatsu,Tokunaga Masahito,Wake Atsushi,Nakano Nobuaki,Eto Tetsuya,Hidaka Michihiro,Choi Ilseung,Miyamoto Toshihiro,Uchida Naoyuki,Moriuchi Yukiyoshi,Miyazaki Yasuhiko,Fukuda Takahiro,Ichinohe Tatsuo,Atsuta Yoshiko,Yoshimitsu Makoto,Ishida Takashi,Utsunomiya Atae,Kato Koji,Suzumiya Junji,Tobai Tomomi,Nakase Koichi,Nawa Yuichiro,Hishizawa Masakatsu,Fukushima Takuya,Wake Atsushi,Choi Ilseung,Asakura Yoshitaka,Nakano Nobuaki,Fujiwara Hiroshi,Machida Shinichiro,Sawayama Yasushi,Inoue Yoshitaka,Imada Kazunori,Yoshida Isao,Fuji Shigeo,Fukuda Takahiro,Shindo Takero,Tokunaga Masahito,Muranushi Hiroyuki,Morishima Satoko,Tomori Shohei,Iemura Tomoki,Shimizu Takuya,Morita-Fujita Mari,Kato Koji,

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-00996-y.pdf

Reference47 articles.

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481–92.

2. Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, et al. Revised adult T-cell leukemia-lymphoma international consensus meeting report. J Clin Oncol. 2019;37:677–87. https://doi.org/10.1200/JCO.18.00501.

3. Tsukasaki K, Fukushima T. JSH practical guidelines for hematological malignancies, 2018: II. lymphoma-8. adult T-cell leukemia-lymphoma. Int J Hematol. 2019;109:249–59. https://doi.org/10.1007/s12185-018-02588-5.

4. Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 2014;15:e517–26.

5. Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25:5458–64. https://doi.org/10.1200/JCO.2007.11.9958.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometric profiles with CD7 and CADM1 in CD4+ T cells are promising indicators for prognosis of aggressive ATL;Blood Advances;2024-07-12

2. A comparison of long-term outcomes by donor type in the era of post-transplantation cyclophosphamide for aggressive adult T-cell leukemia/lymphoma;Bone Marrow Transplantation;2024-02-14

3. Selective histone deacetylase inhibitor after allo-HCT for T-cell acute lymphoblastic leukemia or T-cell lymphoma;Bone Marrow Transplantation;2024-01-23

4. Epigenetic Alterations That Are the Backbone of Immune Evasion in T-cell Malignancies;Cureus;2024-01-04

5. Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey;The Lancet Regional Health - Western Pacific;2023-11